Induction of Apoptosis by a Hepatocyte Conditioned Medium

Journal of Cellular Physiology

Volumn 198, Issue 3, 2004, Pages 452-460

  Bresgen, Nikolaus ^a   Rolinek, R ^a   Hochleitner, E ^b   Lottspeich, F ^b   Eckl, P M ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; ISOFERRITIN;

ANIMAL; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL CULTURE; CELL DEATH; CELL STRUCTURE; CHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; FEMALE; GROWTH INHIBITION; INCUBATION TIME; LIVER CELL; LIVER CELL CULTURE; LIVER PARENCHYMA; LONG TERM CARE; NECROSIS; NICK END LABELING; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; RAT STRAIN; SEQUENCE HOMOLOGY; STATISTICAL SIGNIFICANCE; TIME;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FERRITINS; HEPATOCYTES; IN SITU NICK-END LABELING; NECROSIS; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 1242272146     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10439     Document Type: Article

References (38)

1. Bailly-Maitre B, de Sousa G, Zucchini N, Gugenheim J, Boulukos KE, Rahmani R. 2002. Spontaneous apoptosis in primary cultures of human and rat hepatocytes: Molecular mechanisms and regulation by dexamethasone. Cell Death Differ 9:945-955.
2. Bishr Omary M, Ku NO, Toivola DM. 2002. Keratins: Guardians of the liver. Hepatology 35(2):251-257.
3. Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldmann G, Henin D, Degott C. 1997. Apoptosis after ischemiareperfusion in human liver allografts. Liver Transpl Surg 3(4): 407-415.
4. Bresgen N, Eckl PM. 1996. Effects of hepatocyte conditioned medium on primary hepatocyte cultures. Ber Nat-Med Ver Salzburg 11:61-72.
5. Bresgen N, Eckl PM. 1999. Influence of dexamethasone and growth promoting regimens on apoptosis induction by a hepatocyte conditioned medium. Proceedings of the 90th annual meeting of the American Association for Cancer Research, Philadelphia 1999, Vol. 40. Philadelphia: American Association for Cancer Research. 323.
6. Broxmeyer HE, Bognacki J, Dorner MH, de Sousa M. 1981. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med 153(6):1426-1444.
7. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. 1990. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11(5):847-853.
8. 1 treatment. Cytometry 23(4):312-321.
9. Collin C, Moll R, Kubicka S, Ouhayoun JP, Franke WW. 1992. Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. Exp Cell Res 202(1):132-141.
10. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. 1995. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis and autolytic cell death: A cautionary note. Hepatology 21(5):1465-1468.
11. Gressner AM, Lahme B, Mannherz HG. 1997. TGF β mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 26(5):1079-1092.
12. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillett NA. 1994. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 20(4 Part 1):854-862.
13. Kim JS, Qian T, Lemasters JJ. 2003. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology 124(2):494-503.
14. Konikoff F, Shoenfeld Y, Isenberg DA, Theodor F, Moroz C. 1987. Placental type isoferritins in chronic liver diseases. Hepatogastroenterology 34(2):65-67.
15. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNFα requires transcriptional arrest. J Immunol 153(4):1778-1788.
17. Maeda S, Kimura H, Koga N, Lin KH, Saito T. 1993. Cell density-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes. Biochem Biophys Res Commun 195(1):270-275.
18. Michalopoulos G, Cianciulli D, Novotny AR, Kligerman AD, Strom SC, Jirtle RL. 1982. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 42:4673-4682.
19. Moroz C, Kupfer B, Twig S, Parhami-Seren B. 1985. Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin Chim Acta 148(2):111-118.
20. Moroz C, Traub L, Maymon R, Zahalka MA. 2002. PLIF, a novel human ferritin subunit from placenta with immunosuppressive activity. J Biol Chem 277(15):12901-12905.
21. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR. 1997. Drug induced apoptosis in hepatoma cells is mediated by the CD95(APO-1/Fas) receptor/ligand system and involves activation of wild type p53. J Clin Invest 99(3):403-413.
22. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura A, Ogasawara J, Nagata S. 1994. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 215(2):332-337.
23. 1. PNAS 89(12):5408-5412.
24. Raffray M, Cohen GM. 1997. Apoptosis and necrosis in toxicology: A continuum or distinct modes of cell death? Pharmacol Ther 75(3): 153-177.
25. Reinerova M, Veselovska C, Ausch H, Rosen HR. 1996. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43. Neoplasma 43(6):363-366.
26. Rosen HR. 1996. Placental isoferritin-associated p43 in pregnancy and breast cancer. Minireview. Neoplasma 43(6):357-362.
27. Rosen HR, Flex D, Stierer M, Moroz C. 1991. Monoclonal antibody CM-H-9 detects circulating placental isoferritin in the serum of patients with visceral metastases of breast cancer. Cancer Lett 59(2):145-151.
28. Rosen HR, Ausch C, Reinerova M, Zaspin E, Renner K, Rosen AC, Schiessel R, Moroz C. 1998. Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells-A cpossible role for breast cancer-associated p43. Cancer Lett 127(1-2):129-134.
29. Rouquet N, Carlier K, Briand P, Wiels J, Joulin V. 1996. Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem Biophys Res Commun 229(1):27-35.
30. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Oberhammer F, Wagner A, Jirtle R. 1993. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ Health Perspect 101(Suppl 5):87-90.
31. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Mullauer L, Ruttkay-Nedecky B. 1995. Apoptosis and multistage carcinogenesis in rat liver. Mutat Res 333(1-2):81-87.
32. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG. 1993. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18(2):347-356.
33. Shimamatsu K, Wanless IR. 1997. Role of ischemia in causing apoptosis, atrophy and nodular hyperplasia in human liver. Hepatology 26(2):343-350.
34. Shimizu S, Eguchi Y, Kamiike W, Akao Y, Hasegawa J, Matsuda H, Tsujimoto Y. 1996. Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes. Am J Physiol 271(6 Part 1):949-958.
35. Sirota L, Kupfer B, Moroz C. 1989. Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol 77(2):257-262.
36. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. 1997. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90(12):4979-4986.
37. Wyllie AH. 1992. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev 11:95-103.
38. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, Kojima I. 1993. Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92(3):1491-1496.